Shanghai, China

Xiaodong Xi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Illinois. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaodong Xi. Retrieved from https://idiyas.com/inventor/xiaodong-xi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Platelet Aggregation Inhibition by Xiaodong Xi

Introduction

Xiaodong Xi is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical science, particularly in the modulation of platelet aggregation. His work focuses on developing methods and compositions that can inhibit platelet cell aggregation, which is crucial in treating clot-related diseases.

Latest Patents

Xiaodong Xi holds 1 patent for his innovative work titled "Modulation of platelet aggregation." This patent describes methods and compositions that utilize cell permeant RGT peptides, specifically RGT bound to a lipid moiety. These compositions are designed to be used in the treatment and prevention of serious conditions such as stroke and myocardial infarction.

Career Highlights

Xiaodong Xi is affiliated with the University of Illinois, where he continues to advance his research in the medical field. His expertise in platelet aggregation has positioned him as a valuable contributor to the scientific community.

Collaborations

Xiaodong Xi collaborates with Xiaoping Du, enhancing the research efforts in their shared field of study.

Conclusion

Xiaodong Xi's innovative work in the modulation of platelet aggregation represents a significant advancement in medical science. His contributions have the potential to improve treatment options for patients suffering from clot-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…